Vildagliptin in New Onset Diabetes After Transplantation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The purpose of this study is to determine whether monotherapy with Vildagliptin improve glycemic control in kidney transplanted patients with newly diagnosed New Onset Diabetes after Transplantation (NODAT).
Epistemonikos ID: bc160985301c631d4bf9cc6ec60216ed407161d9
First added on: May 05, 2024